Pfizer Comirnaty COVID19 Vaccination information

You are  able to access the latest Australian Government information on COVID-19 vaccines and the vaccine roll-out via the Department of Health (DoH) COVID-19 vaccine website. The are frequent updates to this is website as the situation evolves.

Current guidance includes:

Page under development Come back tomorrow (Sunday 15 August 2021) to read more

In the meantime access the Government info on Pfizer Comirnaty here:

https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/learn-about-covid-19-vaccines/about-the-pfizerbiontech-covid-19-vaccine

COVID-19 vaccination – Information on COVID-19 Pfizer (COMIRNATY) vaccine

COVID-19 vaccination – After your Pfizer (COMIRNATY) vaccine

Booking appointments  for Pfizer Comirnarty COVID19 vaccination at Reydon Street. We are currently providing vaccinations for 16 to 59 yrs olds.

When Booking an appointment at Reydon Street, you will need:

  • A current Medicare Care Card (check expiry date)
  • Photo ID
  • Proof of eligibility for Pfizer Comirnaty COVID19 vaccination (check below)

We will be checking photo ID and Medicare cards when people arrive at their appointment, and you will need to use your details to book these appointments.

For 16 to 59 year olds, photo ID confirming age will be enough (if we do not already have this on record).

If  you are 15  years and under, or 60 years and over we do not have capacity to offer a vaccination appointment.

We recommend  you use the Eligibility Checker to find a suitable location https://www.health.gov.au/resources/apps-and-tools/covid-19-vaccine-eligibility-checker or book through Queensland Health https://www.qld.gov.au/health/conditions/health-alerts/coronavirus-covid-19/protect-yourself-others/covid-19-vaccine/book

Wherever they attend, patients who are between 16 to 59 year old will need to provide additional proof of eligibility for a Pfizer vaccination before they can be vaccinated. This may be a health summary from a specialist/GP, proof of being a carer, a letter from your employer or their Eligibility Declaration.

You can print an Eligibility Declaration form at: https://www.health.gov.au/resources/publications/covid-19-vaccination-eligibility-declaration-form. You will need to bring the completed form with you.

Dosing schedule

The standard interval between first and second dose is 21 days. At present you will have a 2nd dose appointment booked for the same time of day 21 days later.

You will need to be available for BOTH appointments.

The interval may change in light of supply and demand for COVID19 vaccination as the rate of infection in the community changes.

Queensland State Government makes Pfizer Comirnaty vaccination available to additional groups.

These  patients cannot book at Reydon Street Medical Centre, and need to access the vaccination through a Queensland Health location.

To check eligibility and book appointments, visit:

https://www.qld.gov.au/health/conditions/health-alerts/coronavirus-covid-19/protect-yourself-others/covid-19-vaccine/rollout

To see if you are eligible to receive a vaccine through Queensland Health  access https://www.qld.gov.au/health/conditions/health-alerts/coronavirus-covid-19/protect-yourself-others/covid-19-vaccine/book

 

Patients aged 60 years and over wanting access Pfizer Comirnaty instead of AstraZeneca COVID19 vaccine:

A group of patients should avoid AstraZeneca a precautionary measure, and are recommended to receive Pfizer Comirnaty instead:

These are patients with a past history of:

  • cerebral venous sinus thrombosis (CVST)
  • heparin induced thrombocytopenia (HIT)
  • idiopathic splanchnic (mesenteric, portal, splenic) vein thrombosis, and
  • antiphospholipid syndrome with thrombosis.
  • patients  with an allergic reaction to components of the AstraZeneca Vaccination or significant reaction to a first dose AstraZeneca vaccination.

Pfizer Comirnaty is recommended for the second dose for people in these groups who have received a first dose of COVID-19 Vaccine AstraZeneca.

 

Side effects of Pfizer Comirnaty COVID19 vaccination

You can view the full advice on  what to expect after you vaccination at

https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/getting-vaccinated-for-covid-19/what-happens-after-i-am-vaccinated-for-covid-19

Side effects are usually mild after the first dose of Pfizer , and usually go away within one or two days.  You can take paracetamol or ibuprofen if you need to after your vaccinations. If there is swelling at the injection site, you can use a cold compress /ice pack.

Some recipients will experience more significant flu-like symptoms from this vaccination compared to other common vaccinations and may require time away from normal activities. This is more common after the second dose

Common side effects after Comirnaty include:

 

  • pain or swelling at the injection site
  • tiredness
  • headache
  • muscle pain
  • fever and chills
  • joint pain.

Less common side effects after Comirnaty include

 

  • redness at the injection site
  • nausea
  • enlarged lymph nodes
  • feeling unwell
  • pain in limb insomnia
  • itching at the injection site.

 

Rare side effects that have been reported after Comirnaty are

 

  • severe allergic reaction (anaphylaxis)
  • myocarditis and pericarditis

Most reported cases have been mild, self-limiting and recovered quickly, although longer-term follow-up of these cases is ongoing. Cases have been reported predominantly after the second dose and predominantly in younger males (aged < 30 years)

As this is evolving please read the link for the latest information:

https://www.health.gov.au/resources/publications/covid-19-vaccination-guidance-on-myocarditis-and-pericarditis-after-mrna-covid-19-vaccines

Who shouldn’t have Pfizer Comirnaty COVID19 vaccination?

The following groups should book a discussion appointment to seek additional advice  from a Reydon Street Medical Centre GP before booking a vaccination appointment here.

Cardiac Conditions

  • Myocarditis and pericarditis have been rarely reported after Comirnaty.
  • People who develop myocarditis or pericarditis after having Comirnaty should defer further doses of Comirnaty and discuss this with their treating doctor.
  • People with a past history of inflammatory cardiac illness e.g.:
      • myocarditis,
      • pericarditis,
      • endocarditis;
      • current acute rheumatic fever
  • complex or severe congenital heart disease;
  • acute decompensated heart failure or
  • a history of cardiac transplant

These groups may still be able  to receive Comirnaty, however consultation with a cardiologist is recommended as a precaution prior to booking a vaccination appointment.

 

Past History of mastocytosis, allergy and anaphylaxis

Precautions to the use of both Comirnaty and COVID-19 Vaccine AstraZeneca include a history of generalised (non-anaphylactic) reaction to a prior dose or an ingredient, past anaphylaxis to medications/vaccines which may contain polyethylene glycol or polysorbate 80, and a history of confirmed mastocytosis with recurrent anaphylaxis which requires treatment.

Precautions are required for people with a history of confirmed mastocytosis with recurrent anaphylaxis. Patients with other mast cell disorders can be vaccinated without special precautions.

This may affect choice of vaccine, location of delivery and requires a review appointment with your GP / specialist before booking a vaccination appointment

ATAGI Clinical Guidance on COVID-19 Vaccine in Australia_v6.0 Date: 30 July 2021 3

.

I have heard about possible allergies. What non-active ingredients are included in the Pfizer vaccine ?

None of the vaccine ingredients are of human or animal origin and there are no food, latex or gelatin in the COVID-19 vaccines that are currently available. If individuals have had an allergic reaction to other vaccines in the past, it does not mean that they will also be allergic to the COVID-19 vaccines (Australasian Society of Clinical Immunology and Allergy [ASCIA], 2021).

Patients with allergies to the ingredients  in the vaccination will need to discuss  COVID19 vaccination with their doctor.

The TGA list the following ingredients :

  • ((4-hydroxybutyl)azanediyl)bis(hexane6,1-diyl)bis(2-hexyldecanoate) (ALC0315)
  • 2-[(polyethylene glycol)-2000]-N,Nditetradecylacetamide (ALC-0159)
  • Distearoylphosphatidylcholine (DSPC)
  • Cholesterol
  • Potassium chloride
  • Monobasic potassium phosphate
  • Sodium chloride
  • Dibasic sodium phosphate dihydrate
  • Sucrose
  • Water for injections
Menu